A Simple and Sensitive HPLC Method For Determination of Tacrolimus in Pharmaceutical Dosage Forms

Minevska, Emilija and Apostolova, Paulina and Karpicarov, Dino and Vitanov, Petre and Grozdanov, Anita and Paunovic, Perica and Arsova-Sarafinovska, Zorica (2024) A Simple and Sensitive HPLC Method For Determination of Tacrolimus in Pharmaceutical Dosage Forms. In: 27th Congress of Chemists and Technologists of Macedonia, 25–28 Sept 2024, Metropol Lake Resort, Ohrid, North Macedonia.

[thumbnail of Abstract_Tacrolimus.pdf] Text
Abstract_Tacrolimus.pdf

Download (270kB)
[thumbnail of Programa_27th Congress of SCTM (25-September 28, 2024).pdf] Text
Programa_27th Congress of SCTM (25-September 28, 2024).pdf

Download (297kB)
[thumbnail of Sodrzina_Book of abstracts.pdf] Text
Sodrzina_Book of abstracts.pdf

Download (571kB)
[thumbnail of Poster_Tacrolimus.pdf] Text
Poster_Tacrolimus.pdf

Download (1MB)

Abstract

Tacrolimus (TCL) is an immunosuppressive drug commonly used in organ transplant patient rejection. A simple and sensitive RP–HPLC method with UV detection was developed for determination of tacrolimus in pharmaceuticals. The separation was performed on a Watters ODS 2 column (125 mm x 4.0 mm, 5μm) with a mobile phase consisted of acetonitrile and water acidified to pH of 4.0, 45:55 (V/V). The flow rate was set at 1 mL min-1 and UV detection was performed at 210 nm. The method was validated by determination of system suitability, specificity, linearity, precision, accuracy, limit of detection and limit of quantitation and robustness, following the ICH Q2(R1) guidelines. The advantages of this method were: simple sample preparation, good precision (RSD < 2%) and high recovery (> 99%). Linearity was studied in the range of 0.0397 – 0.318 mg mL-1. The limit of detection was 8.1 μg mL-1, while limit of quantitation was 24.6 μg mL-1. The limit of detection was compared with the one determined by DPV – Differential Pulse Voltammetry for the electrochemical nanosensor for the TCL. The main peak was obtained at 2.2 V for 0.0025M TCL. The method could be applied for routine quality control of pharmaceuticals and for evaluation of potentially counterfeit capsules containing TCL.

Item Type: Conference or Workshop Item (Poster)
Subjects: Medical and Health Sciences > Other medical sciences
Divisions: Faculty of Medical Science
Depositing User: Dino Karpicarov
Date Deposited: 08 Oct 2024 06:50
Last Modified: 08 Oct 2024 06:50
URI: https://eprints.ugd.edu.mk/id/eprint/34794

Actions (login required)

View Item View Item